Concepedia

Erfan Sahebolzamani

ES

5

Publications

145

Citations

5

H-Index

2018

Active since

Affiliations

Tehran University of Medical Sciences(Current)

Roozbeh Hospital

Iran University of Medical Sciences

Erfan Sahebolzamani is an author at Tehran University of Medical Sciences specializing in psychopharmacology, pharmacology, and depression.

Top concepts

Publications per year

2018–2020

5

Publications

5

<i>Crocus sativus</i> L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study

Sara Baziar, Ali Aqamolaei, Ebrahim Khadem et al. · Journal of Child and Adolescent Psychopharmacology · 2019 · 41 citations · Full text

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial

Firouzeh Borhannejad, Behnam Shariati, Sina Naderi et al. · Journal of Clinical Pharmacy and Therapeutics · 2020 · 31 citations

L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial

Behin Araminia, Mohammadreza Shalbafan, Amirhosein Mortezaei et al. · Journal of Affective Disorders · 2020 · 30 citations

, , +10

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control

Sina Naderi, Heidar Faghih, Ali Aqamolaei et al. · Psychiatry and Clinical Neurosciences · 2018 · 23 citations

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control

Farzaneh Yousefzadeh, Erfan Sahebolzamani, Arash Sadri et al. · International Clinical Psychopharmacology · 2020 · 20 citations

, , +21

Rows per page

1–5 of 5